Adult Growth Hormone Deficiency
New England Journal of Medicine (2025) The REDEFINE 1 Phase 3 trial was a landmark 68-week, double-blind, randomized study comparing CagriSema (cagrilintide 2.4 mg plus semaglutide 2.4 mg) with semaglutide alone, cagrilintide alone, and placebo in 3,417 adults with obesity or overweight without diabetes
Synthesis of blood clotting factors : It produces proteins that are crucial for blood clotting, helping to prevent excessive bleeding
In most professional skincare formulations, the peptide is supported by additional ingredients that improve hydration, texture, and overall skin comfort
In Vitro
33 Advances in specific microfluid cell culture systems (e.g., microfabricated fluid channels and microfabricated blood vessel systems) will provide new insights into the cellular mechanisms of arterial stiffness